Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 40   Next >
 
1.  
British HIV Association guidelines for HIV-associated malignancies 2014. 2008 (revised 2014 Mar). NGC:010275
British HIV Association - Disease Specific Society. View all guidelines by the developer(s)
2.  
Adjuvant interferon for malignant melanoma. 2014 Feb. NGC:010377
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
Guidelines for the diagnosis and management of adult myelodysplastic syndromes. 2014 Feb. NGC:010301
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
4.  
Antiretroviral therapy. 2003 Mar (revised 2014 Jan). NGC:010394
New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by the developer(s)
5.  
Prostate cancer: diagnosis and treatment. 2008 Feb (revised 2014 Jan). NGC:010205
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
Non-small cell lung cancer stage IV. 2011 Jun (revised 2013 Nov). NGC:010261
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
Endometrial cancer. 2012 Apr (revised 2013 Sep). NGC:010252
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Uterine sarcoma. 2011 Aug (revised 2013 Sep). NGC:010272
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10.  
Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma). 2011 May (revised 2013 Aug). NGC:010000
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
11.  
Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. 2006 Jun 20 (revised 2013 Jul 1). NGC:010026
American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s)
15.  
Management of in-transit disease of the limbs. 2010 May (revised 2013 Feb). NGC:010259
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Management of resectable stage IV primary cutaneous melanoma without nodal disease. 2010 May (revised 2013 Feb). NGC:010260
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Systemic therapy for unresectable stage III or metastatic cutaneous melanoma. 2012 Mar (revised 2013 Feb). NGC:010269
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
Malignant pleural mesothelioma. 2010 Aug (revised 2012 Dec). NGC:010257
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Thymic neoplasms. 2010 Jun (revised 2012 Dec). NGC:010271
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
20.  
Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer. 2012 Oct 31. NGC:010223
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 40   Next >